October 7, 2022 Moderna Tries to Send Message That It Owns the Commercial Rights to mRNA Technology in Suit Against Pfizer By Avi Strauss
April 29, 2022 Where We Are Now on the COVID-19 TRIPS Proposal—Is an IP Waiver the Right Way to Address Vaccine Inequity? By Kelsey Price
November 17, 2021 Damned If We Don’t and… Also Damned If We Don’t: A Look into the History of Vaccine Mandates and the Future of the COVID-19 Vaccine By Eleesya Cordes